Wednesday 1 June, 2016 Thursday 2 June, 2016 Friday 3 June, 2016 Saturday 4 June, 2016

Wednesday, June 1, 2016
EASO Teaching Courses and Workshops 
08:30 - 12:30 EASO COTF Teaching Course: Multidisciplinary Treatment in Children   Speaker G4 HALL
  Chairs: P Nowicka (Sweden), J Baker (Denmark)    
08:30 - 08:35 Introduction  P Nowicka (Sweden)  
08:35 - 09:35 How to develop national treatment guidelines - the case of Denmark J-C Holm (Denmark)   
09:35 - 10:15 Medical assessment of the obese child and early detection of complications (Physical examination,  exclusion of syndromic obesity, screening of complications) C-E Flodmark (Sweden)  
10:15 - 10:30 Coffee break
10:30 - 11:20 Counseling with no harm – the case of eating disorders (ED). The link between dieting and ED, etiology of ED and iatrogenic factors in weight loss counseling  M Golan (Israel)  
11:20 - 12:20 Early obesity treatment: Motivational work with the parents of the youngest. Current evidence of effectiveness and practical examples  P Nowicka (Sweden)  
08:30 - 12:30 EASO OMTF Teaching Course Multidisciplinary Treatment in Adults   G3 HALL
  Chairs: J Salvador (Spain), V Yumuk (Turkey)     
08:30 - 09:00 Clinical evaluation of the obese patient C Tsigos (Greece)  
09:00 - 09:30 Lifestyle management tips G Roman (Romania)  
09:30 - 10:00 Creating a 'hydragenic environment' for obesity treatment clinics TBC   
10:00 - 10:30 Pharmacotherapy of obesity D Micic (Serbia)  
10:30 - 10:45 Coffee break
10:45 - 11:15 Diabetes treatment in the obese M Holecki (Poland)  
11:15 - 11:45 European guidelines for metabolic surgery M Fried (Czech Republic)  
11:45 - 12:15 Postbariatric surgery follow up D Dicker (Israel)  
12:15 - 12:30 Qs & As Panel   
10:30-12:30 EASO PPHTF Discussion Session: Front-of-package logos – best practices in use   F4+F5 HALL
  Chairs: M Lahti-Koski (Finland), T Visscher (Netherlands)    
10:30 - 10:50 Front-of-package logos: Do they help consumers to make better choices? E. van Kleef (The Netherlands)  
10:50 - 11:10 Front-of-package logos: 10 years of Dutch Choices logo, effects to product innovation and consumers. L Jansen (Neth)  
11:10 - 11:30 FoP logos in Europe: introduction, experiences and areas of cooperation    
  Keyhole – the oldie of the group A Jansson (Sweden)  
  Heart Symbol – the Finnish solution M Lahti-Koski (Finland)  
  Choices - the most international fellow R Schilpzand (Belgium)  
  Colour coded front of pack nutrition labelling – the UK system T.Netherwood (UK)  
12:00 - 12:15 WHO’s activities in promoting reformulation and labelling J Breda (Denmark)  
12:15 - 12:30 Discussion    
12:30 - 15:30 IFSO-EC Pre-Congress Courses 
details about the individual IFSO-EC Pre-Congress Courses can be find here
  Hall to be specified
  E1 - IFSO-EC Pre-Congress Course 1
Experimental and Clinical Research on Bariatric Surgery
  organised by French Society of Bariatric Surgery    
  E3 - IFSO-EC Pre-Congress Course 2
High volume fast track Surgery : Live operations  
  organised by The Icelandic Society for Metabolic and Bariatric Surgery (ISMBS)    
  J2 - IFSO-EC Pre-Congress Course 3
The Scandinavian standardized Roux-en-Y gastric bypass- technique and outcomes"
  organised by Swedish Association for Bariatric Surgery    
12:30 - 14:00 EASO Programme: Oral Sessions and Accepted Symposia 
  OS1 - Oral Session: Prevention and Behaviour   G3 HALL
  Chairs: P Nowicka (Sweden), C Hardman (UK)    
12:30 - 12:40 OS1.01: Maternal sense of coherence and controlling feeding practices: The importance of resilience and support for families with preschoolers P Nowicka (Sweden)  
12:40 - 12:50 OS1.02: The role of adiposity in perceived ability within Ireland's primary education system M Queally (Ireland)  
12:50 - 13:00 OS1.03: The longitudinal relation between accumulation of adverse life events and body mass index from early adolescence to young adulthood
L Elsenburg (Netherlands)  
13:00 - 13:10 OS1.04: Effects of active commuting or leisure time exercise on health-related quality of life in overweight men and women
A Gram (Denmark)  
13:10 - 13:20 OS1.05: A proportionate intervention in school led to improve overweight prevention without aggravating the health social inequalities
P Böhme (France)  
13:20 - 13:30 OS1.06: Primary prevention of childhood obesity within child health services: the PRIMROSE cluster-RCT
N Döring (Sweden)  
13:30 - 13:40 OS2.07: Parental Perception of Child Weight Status and Weight Gain across Childhood E Robinson (UK)  
13:40 - 13:50 OS1.08: Accuracy of weights and heights, self-reported on-line by young adults C Nikolaou (UK)  
13:50 - 14:00 Discussion     
12:30 - 14:00 OS2 - Oral Session: Adipose Tissue Metabolism   G4 HALL
  Chairs: A Rodriguez (Spain), M Rydén (Sweden)    
12:30 - 12:40 OS2.01: Fatty acids intakes are associated with higher apelin gene expression in visceral and subcutaneous adipose tissues
E Yuzbashian (Iran)  
12:40 - 12:50 OS2.02: Mitochondrial oxidative pathways are downregulated in adipocytes in obesity ‒ a study of young healthy MZ twins
S Heinonen (Finland)  
12:50 - 13:00 OS2.03: Environmental factors associated with overweight or obesity development in children in school age in Botucatu, São Paulo, Brazil
R Galvao Cintra (Brazil)  
13:00 - 13:10 OS2.04: Functional characterization of novel cytoskeletal protein SEPT11 in murine and human adipocytes: role in lipid traffic
N Castellanos (Spain)  
13:20 - 13:30 OS2.05: Understanding extracellular and intracellular mediators in subcutaneous and omental adipose tissue related to obesity and insulin resistance M Malagon (Spain)  
13:30 - 13:30 OS2.06: Cell-autonomous brown-like adipogenesis of preadipocytes from retinoblastoma haploinsufficient mice J Ribot (Spain)  
13:30 - 13:40 OS2.XX: Exercise training-induced effects on abdominal subcutaneous adipose tissue gene and protein expression and adipose tissue morphology in obese humans R Stinkens (The Netherlands)  
13:40 - 14:00 Discussion    
12:30 - 14:00 OS3 - Oral Session: Clinical Management 1   F4+F5 HALL
  Chairs: V Yumuk (Turkey), A Janson (Sweden)    
12:30 - 12:40 OS3.01: Improvements in risk factors contribute to the reduction in mortality risk after RYGB in type 2 diabetes: a nationwide, matched, observational cohort study
V Liakopoulos (Sweden)  
12:40 - 12:50 OS3.02: Appetitive characteristics as predictors of quality of life after surgical and conventional treatment of severe obesity: results from the Swedish Obese Subjects study
H Konttinen (Finland)  
12:50 - 13:00 OS3.03: Preoperative Beta Cell Function is Predictive of Diabetes Remission after Bariatric Surgery P Souteiro (Portugal)  
13:00 - 13:10 OS3.04: Early Life Factors Predicting Change in Childhood Body Mass Index J Kerr (Australia)  
13:10 - 13:20 OS3.05: Kids4Fit: evaluation of the effectiveness of a multidisciplinary intervention program for overweight and obese children in deprived areas
K Ligthart (Netherlands)  
13:20 - 13:30 OS3.06: Modifying mainstream weight management interventions for use with people with intellectual disabilities: a user centred approach
L Croot (UK)  
13:30 - 13:40 OS3.07: High prevalence of psychiatric disorders and 6-months weight outcomes of a structured obesity treatment program I Larsson (Sweden)  
13:40 - 13:50 OS3.08: Stigma and Knowledge as Determinants of Recommendation and Referral Behavior of General Practitioners and Internists F Jung (Germany)  
13:50 - 14:00 Discussion     
12:30 - 14:00 AS1 - Symposium: The I.Family cohort: Childhood obesity in relation to genes, families and environments   F1 HALL
12:30 - 12:35 AS1.01: Introduction to the I.Family cohort W Ahrens (Germany)   
12:35 - 12:50 AS1.02: Does the FTO gene interact with the socioeconomic status on obesity development of young European children? Results from the IDEFICS study R Foraita (Germany)   
12:50 - 13:05 AS1.03: Diet and Gene expression C Picó (Spain)   
13:05 - 13:20 AS1.04: Urinary sugars to validate and calibrate dietary instruments: A study on children eating a freely chosen diet
V Pala (Italy)   
13:20 - 13:35 AS1.05: Familial resemblance in nutritional status in I.Family L Bogl (Finland)   
13:35 - 13:50 AS1.06: Peer influences on weight, dietary patterns and physical activity W Gwozdz (Denmark)   
12:30 - 14:00 AS2 - Symposium: Translating Health-Related Quality Of Life (HRQOL) Research into Clinical Practice for Adults and Youth
12:30 - 12:40 AS2.01: Brief overview of Health-Related Quality of Life (HRQOL) RL Kolotkin (US)  
12:40 - 13:00 AS2.01: HRQOL in youth with obesity MH Zeller (US)   
13:00 - 13:20 AS2.01: HRQOL in adults with obesity JR Andersen (Norway)   
13:20 - 13:40 AS2.01: Patient perspective on obesity treatment Ole J Øvretveit (Norway)  
13:40 - 14:00 AS2.01: Facilitated discussion H Rutter (UK)   
12:30 - 14:00 EASO Education Course
  What is Epigenetics? R Loos (U.S.A.)  F3 HALL
  In this education course we will review [1] the basics of genetics and epigenetics, [2] how their role is studied in the context of body weight regulation, [3] what is currently known about their contribution to body weight regulation, [4] and what genetic and epigenetic insights mean for the prevention and treatment of obesity.    
14:00 - 15:30 Review/Workshop Sessions 
14:00 - 15:30 Personalised treatment of obesities   F3 HALL
  Chair: G Frühbeck (Spain)    
14:00 - 14:30 RS1.01: Using Epigenetics R Loos (U.S.A.)  
14:30 - 15:00 RS1.02: Using Omics H Roche (Ireland)  
15:00 - 15:30 RS1.03: The impact of ethnic background N Sattar (UK)  
14:00 - 15:30 RS2 - Browning of WA   G4 HALL
  Chair: E Blaak (Netherlands)    
14:00 - 14:30 RS2.01: Substrate utilisation and metabolic regulation in white and brown adipose tissue S Enerbäck (Sweden)   
14:30 - 15:00 RS2.02: Brown adipose tissue metabolism in man W Van Marken Lichtenbelt (Netherlands)  
15:00 - 15:15 RS2.03: Effect of fatty diet, neurodegeneration and intranasal insulin therapy on the brown adipose tissue-hypothalamic axis Elena Sanguinetti (Italy)  
15:15 - 15:30 RS2.04: Aspiration therapy for obesity; two year results and quality of life Erik Norén (Sweden)  
14:00 - 15:30 RS3 - Novel drug targets for appetite and obesity   F4+F5 HALL
  Chairs: J Halford (UK), J-O Jansson (Sweden)    
14:00 - 14:30 A neural basis for MC4 receptor-regulated appetite L Heisler (UK)  
14:30 - 15:00 Incretin conjugates TD Müller (Germany)  
15:00 - 15:30 Novel drug targets – lessons from bariatric surgery C Le Roux (Ireland)   
14:00 - 15:30 Nutrition: from science to practice (with EFAD)    F1 HALL
  Chairs: E Govers (Netherlands), A Pietrobelli (Italy)     
14:00 - 14:30 RS4.01: Computational modelling of energy balance K Hall (U.S.A.)  
14:30 - 15:00 RS4.02: The role of body composition in nutritional assessment A Bosy-Westphal (Germany)  
15:00 - 15:30 RS4.03: Best practice in nutritional interventions - COMs expertise E Govers (Netherlands), G Roman (Romania)  
14:00 - 15:30 EASO PPHTF and WHO Europe Session 
  Effects of sedentary behavior on obesity and related diseases: measurements, guidelines and population prevention    F2 HALL
  Chairs: J Breda (Denmark), F Rasmussen (Sweden)    
14:00 - 14:05 Introduction. How important is sedentary behavior for health in a global perspective? (5 minutes)    J Breda (Denmark)  
14:05 - 14:30 Beyond Sedentary Time: Breaks, Bouts and Obesity Phenotypes in Older Adults. L Sardinha (Portugal)  
14:30 - 14:55 Sedentary behavior in working life. Which are the health implications? S Clemes (UK)  
14:55 - 15:20 Sedentary behavior among children in Europe. Is it important for health and obesity? F Rasmussen (Sweden)  
15:20 - 15:30 Wrapping up and closure of session J Breda (Denmark)  
15:30 - 16:00 Coffee Break/Commercial Exhibition 
16:00 - 17:30 Industry Supported Sessions 
16:00 - 17:30 EASO Industry Supported Session: Satellite Symposium   G3 HALL
  Changing perceptions of obesity and its related comorbidities    
16:00 - 16:10 Welcome and introduction Jarl Torgerson (Sweden)  
16:10 - 16:30 Uncovering the risks associated with obesity Kirsi Pietiläinen (Finland)  
16:30 - 16:50 Management of obesity: what options do we have? John Wilding (UK)  
16:50 - 17:10 From clinical trials to clinical practice Luc Van Gaal (Belgium)  
17:10 - 17:25 Panel discussion All Faculty  
17.25 - 17.30 Summary and close Jarl S Torgerson (Sweden)  
17:30 - 21:00 Opening Ceremony and Welcome Reception
17:30 - 18:15 JOPL - Joint Opening Plenary Lecture: Lessons from SOS LM Carlsson (Sweden) MAIN HALL
18:15 - 19:15 Opening Ceremony    MAIN HALL
  EASO Patient Council Presentation    
  EASO New Investigator Award Lectures    
19:15 - 21:00 Welcome Reception    EXHIBITION AREA

Thursday, June 2, 2016
08:00 - 09:30 Joint Plenary Session  
 08:00 - 09:30 PL1 - When do you treat Type II Diabetes with Surgery   MAIN HALL
  Chairs: R Batterham (UK), D Dicker (Israel)    
08:00 - 08:20 PL1.01: What is the evidence of BMI? P Schauer (U.S.A)  
08:20 - 08:40 PL1.02: Metabolic surgery in the treatment algorithm for type 2 diabetes D Cummings (U.S.A)  
08:40 - 09:00 PL1.03: Role of the gut on glucose homeostasis: lesson learned from metabolic surgery G Mingrone (Italy)  
09:00 - 09:20 PL1.04: Critical evaluation of metabolic surgery in obese diabetic patients G Schernthaner (Austria)   
09:20 - 09:30 Discussion    
09:30 - 11:00 Review/Workshop Sessions 
09:30 - 11:00 RS5 - New aspects on metabolic control   G3 HALL
  Chairs: S Dickson (Sweden), Y Schutz (Switzerland)    
09:30 - 10:00 RS5.01: Neurobiology of reduced thermogenesis during dieting R Adan (The Netherlands)  
10:00 - 10:30 RS5.02: The role of non-neuronal cells in energy balance J Chowen (Spain)  
10:30 - 11:00 RS5.03: The importance of sleep in metabolic disorders C Benedict (Sweden)  
09:30 - 11:00 RS6 - Weight maintenance: is it achievable?   G4 HALL
  Chair: B Heitmann (Denmark)     
09:30 - 09:50 RS6.01: Body composition changes A Rodriguez (Spain)  
09:50 - 10:10 RS6.02: European registry M Hassapidou (Greece)  
10:10 - 10:30 RS6.03: What distinguishes weight loss maintenance from the general population? M de Zwaan (Germany)  
10:30 - 10:50 RS6.04: Predictors of weight loss maintenance J Stubbs (UK)  
09:30 - 11:00 RS7 - Childhood obesity across Europe   F4+F5 HALL
  Chairs: AJ Baker (Denmark), C Summerbell (UK)     
09:30 - 09:50 RS7.01: A clinical insight T Reinehr (Germany)  
09:50 - 10:10 RS7.02: Healthy nutrition: What do we know and recommend? H Szajewska (Poland)  
10:10 - 10:30 RS7.03: New trends in sedentary activity among European children. N Cavill (UK)  
10:30 - 10:50 RS7.04: Self-esteem and social acceptance at school. M Golan (Israel)  
09:30 - 11:00 RS8 - Microbiome   F1 HALL
  Chair: G Goossens (The Netherlands)    
09:30 - 10:00 RS8.01: Does the gut microbiota mediate the positive metabolic affects following Bariatric surgery
F Bäckhed (Sweden)  
10:00 - 10:30 RS8.02: How does surgery impact on the human microbiota K Clément (France)  
10:30 - 11:00 RS8.03: Fecal transplantation as a metabolic treatment in humans M Nieuwdorp (The Netherlands)  
09:30 - 11:00 RS9 - IFSO-EC Session - Young IFSO Session: Long-term side effects of bariatric surgery
  Chairs: K Dolezalova (Czech Republic), S Weiner (Germany), E Taskin (Turkey)    
09:30 - 09:42 RS9.01: Motivations for seeking bariatric surgery – the importance of health professionals and social networks MJ Sharman (Australia)  
09:42 - 09:54 RS9.02: Risk factors for complications after bariatric surgery P Major (Poland)  
09:54 - 10:06 RS9.03: Mesenteric defect closure After Laparoscopic Roux-en-Y Gastric Bypass A Almunifi (France)  
10:06 - 10:18 RS9.04: Changing levels of pth after scopinaro biliopancreatic bypass surgery A Bianchi (Spain)  
10:18 - 10:30 RS9.05: A single center review of reversal and conversion from Roux-en-Y gastric bypass to Normal anatomy and sleeve gastrectomy A Curell (Spain)  
10:30 - 10:42 RS9.06: Taste Sensory Changes in Morbidly Obese Patients Who Are Applied Laparoscopic Adjustable Gastric Band FM Avsar (Turkey)  
10:42 - 10:54 RS9.07: Desire for core tastes decreases rapidly following laparoscopic sleeve gastrectomy. A single-center longitudinal observational study with 6 months followup
D Gero (France)  
10:54 - 11:00 Discussion    
09:30 - 11:00 RS10 - IFSO-EC Session: Complications   F3 HALL
  Chairs: A Thorell (Sweden), J Himpens (Belgium)    
09:30 - 09:40 RS10.01: Roux-Y fistulo-jejunostomy as a salvage procedure in patients with postsleeve gastrectomy fistula mid term results Y Alassaf (France)  
09:40 - 09:50 RS10.02: Percutaneous gastrostomy is an effective treatment for some chronic conditions following obesity surgery H Gudem (Norway)  
09:50 - 10:00 RS10.03: Revisional surgery to the JJ to alleviate symptoms from kinking at the JJ post LGBP – a cohort study from Sahlgrenska University Hospital
S Hedberg (Sweden)  
10:00 - 10:10 RS10.04: Internal hernia after laparoscopic gastric bypass: effect of closure of the Petersen’s space M Blockhuys (Belgium)  
10:10 - 10:20 RS10.05: Prediction model for hemorrhagic complications after Laparoscopic Sleeve Gastrectomy
M Janik (Poland)  
10:20 - 10:30 RS10.06: Short-term outcomes of laparoscopic sleeve gastrectomy on gastroesophageal reflux disease: does the bougie size matter? M Garay Solà (Spain)  
10:30 - 10:40 RS10.07: Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass at our institution. Indications and first-year postoperative outcome
M Recarte (Spain)  
10:40 - 10:50 RS10.08: Laparoscopic proximal banding after failed gastric bypass, and sleeve gastrectomy; a historical cohort study
E Avinoah (Israel)  
11:00 - 11:30 Coffee Break/Commercial Exhibition  
11:30 - 13:00 Oral Sessions and Symposia 
11:30 - 13:00 EASO Healthy Hydration Working Group: Healthy hydration in nutrition guidelines and policies - how much longer until action is taken?   F4+F5 HALL
  Chairs: N Farpour-Lambert (Switzerland), M Lafontan (France)    
11:30 - 11:55 Beverage-induced caloric intake by SSBs leading to weight gain & obesity risks: a systematic review from 2013 - 2015 M Luger (Austria)  
11:55 - 12:20 Liq.In7, the fluid intake database for a global view of fluid intake behaviors J Gandy (UK)  
12:20 - 12:45 Healthy Hydration: from knowledge to daily dietary practice and nutrition policies P Douglas (UK)  
12:45 - 13:00 Discussion    
11:30 - 13:00 AS3 - Symposium: Eating, addiction and behaviour: a psychological perspective   G3 HALL
  Chairs: J Blundell (UK), J Halford (UK)     
11:30 - 11:50 AS3.01: Are eating-related ‘addictions’ a cause for concern or empty concepts? G Finlayson (UK)  
11:50 - 12:10 AS3.01: “Food addiction” and cue reactivity: Headlines and hyperbole P Christiansen (UK)  
12:10 - 12:30 AS3.01: To what extent does food addiction overlap with eating disorder symptomatology?
J Hebebrand (Germany)  
12:30 - 12:50 AS3.01: The effects of believing in food addiction on eating behaviour C Hardman (UK)  
12:50 - 13:00 Discussion Panel  
11:30 - 13:00 AS4 - Symposium: Environmental Chemicals and Obesity: Focus on Mechanisms   G4 HALL
  Chair : M Ross (U.S.A.)    
11:30 - 11:35 AS4.01: Introduction and Overview M Ross (U.S.A)  
11:35 - 12:00 AS4.01: Environmental Chemicals, Stem Cell Differentiation into Adipocytes and Transgenerational Inheritance of Obesity
B Blumberg (U.S.A)  
12:00 - 12:25 AS4.01: Environmental Chemicals, Thermogenesis and Obesity M La Merrill (U.S.A)  
12:25 - 12:50 AS4.01: Environmental Chemicals and Regulation of Hypothalamic Appetite and Satiety Neurons by Leading to Obesity
M Ross (U.S.A)  
12:50 - 13:00 Discussion  Panel   
11:30 - 13:00 OS4 - IFSO-EC Oral Session: Effect of surgery on T2DM / Managing poor weight loss   F1 HALL
  Chairs: C Le Roux (UK), M Bueter (Switzerland)    
11:30 - 11:40 OS4.01: Overview of procedures
Y Yashkov (Russia)  
11:40 - 11:50 OS4.02: Differences in glucose and insulin dynamics between mini- and Roux-en-Y gastric bypass in euglycemic patients, submitted to a glucose challenge
J Himpens (Belgium)  
11:50 - 12:00 OS4.03: Sleeve gastrectomy in patients with diabetes mellitus type 2. A case series of 260 patients
C Guixé (Chile)  
12:00 - 12:10 OS4.04: 2-year post-operative weight-loss and glycaemic outcomes in patients with type 2 diabetes following Roux-en-Y gastric bypass and sleeve gastrectomy: the role of weight-loss
A Pucci (UK)  
12:10 - 12:20 OS4.05: Usefulness and reliability of upper gastro intestinal contrast studies in assessment of pouch size in patients with weight loss failure after Roux-en-Y gastric bypass
M Uittenbogaart (The Netherlands)  
12:20 - 12:30 OS4.06: Preoperative assessment of motivation is not predictive for weight loss after Roux-en-Y gastric bypass
O Tettero (The Netherlands)  
12:30 - 12:40 OS4.07: A longer biliopancreatic limb Roux-en-Y gastric bypass as revisional bariatric procedure after adjustable gastric banding results in more weight loss: a randomized controlled trial
J Homan (The Netherlands)  
12:40 - 12:50 OS4.08: Laparoscopic Roux-y-gastric bypass conversion of failed laparoscopic gastric band: Outcones with uo to five year follow-up
B Safadi (Lebanon)  
11:30 - 13:00 RS11 - EASO Session - Fiscal measures: taxes, subsidies, incentives   F2 HALL
  Chairs: J Breda (Denmark), L M Encarnación Cruz(Mexico)    
11:30 - 11:50 RS11.01: The Danish story J Jensen (Denmark)  
11:50 - 12:10 RS11.02: Frence Soda Tax O Allais (France)  
12:10 - 12:30   RS11.03: Incentivising health in the workplace M Gabrijelcic (Slovenia)  
12:30 - 12:45 RS11.04: The effect of influencing autonomy for obesity prevention: A review and meta-analysis of school based interventions
E Haynes (Australia)  
12:45 - 13:00 RS11.05: Exploring Malta's food and build environment D Cauchi (UK)  
11:30 - 13:00 RS12 - IFSO-EC Session - Value of registries   F3 HALL
  Chairs: R Welbourn (UK), M Wirén (Sweden)    
11:30 - 12:00 RS12.01: Scandinavian obesity surgery registry I Näslund (Sweden)  
12:00 - 12:10 RS12.02: Sleeve gastrectomy vs Roux-en-Y gastric bypass. Analysis of data from the IFSO-European Chapter Center of Excellence program
J Melissas (Greece)  
12:10 - 12:20 RS12.03: Postoperative complications within 30 days at an academic teaching hospital - analysis of 2000 cases
V Lange (Germany)  
12:20 - 12:30 RS12.04: What happened to gastric band patients during follow up of 14 years SS Ahmad (Jordan)  
12:30 - 12:40 RS12.05: Band to bypass versus Band to Sleeve: 5 years outcomes A Vitiello (Italy)  
12:40 - 12:50 RS12.06: Banded versus non-banded laparoscopic gastric bypass: 434 consecutive patients with a minimum 5 y follow-up
L Lemmens (Belgium)  
12:50 - 13:00 RS12.07: The significant improvement of quality of life in morbidly obese patients after laparoscopic sleeve gastrectomy M Pedonomou (Cyprus)  
13:00 - 15:00 Lunch and Exhibition
13:15 - 14:45 EASO Education Session
  Childhood obesity: failure conversation maps M Golan (Israel) F3 HALL
  This workshop will explore therapeutic options relevant to addressing the sense of personal failure while counseling children and/or parents in  childhood obesity. Offering clinicians a map for themselves as well as a tool to guide therapeutic explorations in this area, and interspersed with transcripts of therapeutic conversations.    
13:15 - 14:45 Industry Supported Sessions 
13:15 - 14:45 EASO Industry Supported Session: Satellite Symposium   G3 HALL
13:15 - 14:45 Medtronic Satellite Symposium   F1 HALL
  Reducing Complications and Optimising Weight Loss in Sleeve Gastrectomy    
  Chair: A Ahmed (UK)    
  Reducing complications and optimising weight loss in sleeve gastrectomy A Trivedi (U.S.A.)  
  Addressing anaesthetic challenges associated with bariatric patients J Cousins (UK)  
  Personal experience with delivering consistent outcomes in sleeve gastrectomy A Ahmed (UK)  
13:15 - 14:45  Ethicon Satellite Symposium   F1 HALL
  A multi-disciplinary approach for evidence based policy making for Obesity    
  Chair: F Erixon (Sweden)    
  Further information will be available in due course     
15:00 - 15:45 Plenary Lectures 
15:00 - 15:45 PL2 - EASO Plenary Session: Sustainable Choices   F4+F5 HALL
  Chair: H Rutter (UK)     
  PL2.01: Sustainable Choices R Stancliffe (UK)   
15:00 - 15:45 PL3 - IFSO-EC Plenary Session: Internal hernias after laparoscopic gastric bypass   MAIN HALL
  Chairs: P Shauer (U.S.A.), M Sundbom (Sweden)    
15:00 - 15:15 PL3.01: Delayed Pain after Gastric Bypass – Do not delay ! A Fiennes (UK)  
15:15 - 15:25 PL3.02: Closure or non-closure of mesenteric defects: results of a PRT E Stenberg (Sweden)  
15:25 - 15:32 PL3.03: How to close the mesenteric defects in ante-colic ante-gastric RYGBP (video) T Olbers (Sweden)  
15:32 - 15:39 PL3.04: How to close the mesenteric defects in retro-colic restro-gastric RYGBP (video) M Suter (Switzerland)  
15:39 - 15:46 PL3.05: Laparoscopic revision of internal hernia after Roux en Y gastric bypass C Pizzera (Austria)  
16:00 - 16:30   Coffee Break/Commercial Exhibition  
16:30 - 18:00  Review/Workshop Sessions
16:30 - 18:00 RS13 - Interorgan crosstalk   G4 HALL
  Chairs: E Blaak (The Netherlands), M Ryden (Sweden)    
16:30 - 17:00 RS13.01: Between the gut and white adipose tissue S Kersten (The Netherlands)   
17:00 - 17:30 RS13.02: Between the gut-and the brain K Murphy (UK)  
17:30 - 18:00 RS13.03: Between the gut and the liver B Staels (France)  
16:30 - 18:00 Obesity and cancer    F4+F5 HALL
  Chairs: D Micic (Serbia)    
16:30 - 17:00 RS14.01: Epidemiology and cancer J Baker (Denmark)  
17:00 - 17:30 RS14.02: Molecular targeting of obesity pathways in cancer R Ribeiro (Portugal)  
17:30 - 18:00 RS14.03: Obesity is a new major cause of cancer A Renehan (UK)  
16:30 - 18:00 RS15 - Joint Session: Mechanisms in bariatric surgery   G3 HALL
  Chairs: N Scopinaro (Italy), B Ludvik (Austria)    
16:30 - 16:50 RS15.01: Gut hormones J Holst (Denmark)  
16:50 - 17:10 RS15.02: Bile diversion and intestinal glucose uptake F Pattou (France)  
17:10 - 17:30 RS15.03: Mechanisms underlying reversal of diabetes by calorie restriction alone R Taylor (UK)  
17:30 - 17:50 RS15.04: Changing reward pathways T Goldstone (UK)  
16:30 - 18:00 Joint New Investigators Session    F3 HALL
16:30 - 16:35 Welcome and Introductions EASO NIU Board    
16:35 - 17:05 EASO NIU Best Thesis Award Presentations
Candidate 1: E Dirinck (Belgum)
Candidate 2: A Perez-Cornago (Spain)
17:05 - 17:30 Senior Presentation 1: How to publish your paper in a top journal J Hebebrand (Germany)  
17:30 - 17:55 Senior Presentation 2: Carbohydrates and body weight regulation – myths and facts A Raben (Denmark)  
17:55 - 18:00 Announcement of EASO NIU Best Thesis Award    
16:30 - 18:00 OS5 - IFSO-EC Abstract Session: Miscelaneous   F1 HALL
  Chairs: Y Yashkov (Russia), T Mala (Norway)    
16:30 - 16:40 OS5.01: 12 month randomized sham controlled trial evaluating the efficacy and safety of targeted use of endoscopic suture anchors for primary obesity: The Essential study T Lavin (U.S.A.)  
16:40 - 16:50 OS5.02: Sleeve gastrectomy in patients with BMI between 30 and 35, with 3 years of follow up.
M Berry (Chile)  
16:50 - 17:00 OS5.03: Effects of depressive disorders and their therapies on the postoperative weight loss after a Roux-en-Y gastric bypass: Do they matter?
P Plaeke (Belgium)  
17:00 - 17:10 OS5.04: 5-Year outcomes of laparoscopic greater curvature plication (LGCP) for treatment of morbid obesity
K Dolezalova (Czech Republic)  
17:10 - 17:20 OS5.05: Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Bariatric Surgery D Kröll (Switzerland)  
17:20 - 17:30 OS5.06: Percutaneous electrical neurostimulation (PENS) of dermatome T6 with an ambulatory self-applied patch vs PENS of dermatome T6 with conventional procedure M Abdel-Kadar (United Arab Emirates)  
17:30 - 17:40 OS5.07: Efficacy and safety of the duodenal-jejunal bypass liner: a prospective cohort study
J Homan (The Netherlands)  
17:40 - 17:50 OS5.08: Weight loss at three months after Roux-en-Y gastric bypass predicts longterm outcome O Tettero (The Netherlands)  
17:50 - 18:00 Discussion    
16:30 - 18:00 IFSO-EC Video Session: Revisional surgery    F2 HALL
  Chairs: N Zundel (USA), J Kristinsson (Norway)    
16:30 - 16:40 OS6.01: Revision bariatric surgery: the gastric bypass as last resort K Devroe (Belgium)  
16:40 - 16:50 OS6.02: Removing a gastric bypass and restoration of normal anatomic continuity P Fournier (Switzerland)  
16:50 - 17:00 OS6.03: Video Presentation: Revisional surgery - failed gastric plication to laparoscopic sleeve gastrectomy
M Taskin (Turkey)  
17:00 - 17:10 OS6.04: First Laparoscopic Biliopancreatic Diversion with Duodenal Switch in Ukraine, in patient with abdominal adhesions after destructive cholecystitis K Mylytsya (Ukraine)  
17:10 - 17:20 OS6.05: Immediate migration of the gastric tube follwoing Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair: A word of caution
B Safadi (Lebanon)  
17:20 - 17:30 OS6.06: Revisional laparoscopic gastric pouch resizing for insufficient weight loss after open Roux-en-Y gastric bypass M Recarte (Spain)  
17:30 - 17:40 OS6.07: Reversal and conversion from an open banded transmesocolic Roux-Y gastric bypass to sleeve gastrectomy for severe hypoglycemia
R Vilallonga (Spain)  
17:40 - 17:50 OS6.08: Surgical revisional approach of gastro-oesophageal reflux after bariatric surgery
A Albuquerque (Portugal)  
17:50 - 18:00 OS6.09: Intraoperative management of jejunojejunostomy error in laparoscopic Roux-en-Y gastric bypass: a potentially deadly, catastrophic event
W Yang (China)  
18:00 - 19:30 Oral Session, Symposium 
18:00 - 19:30 OS7 - Oral Session: Growth/Early Life   G4 HALL
  Chairs: J Baker (Denmark), L Lissner (Sweden)    
  OS7.01: Early-life body mass index (BMI) trajectories associated with resolution of youth obesity
C Magnussen (Australia)  
  OS7.02: Maternal obesity, overweight and gestational diabetes affect the offspring neurodevelopment at 6-year of age – a follow up from the PREOBE cohort
FJT Espínola (Spain)  
  OS7.03: Childhood height and body mass index at 7 years of age and incidence of adult type 2 diabetes
L Geisler Bjerregaard (Denmark)  
  OS7.04: Childhood body mass index and the risk of colon and rectal cancer in adulthood
BW Jensen (Denmark)  
  OS7.05: Blood fatty acid composition in relation to obesity in children aged 2 – 11: results from the European IDEFICS study
K Mehlig (Sweden)  
  OS7.06: The Swedish childhood obesity epidemic over seven decades: starts 1971, peaks 1991, and stabilizes afterwards – The BEST cohort
M Bygdell (Sweden)  
  OS7.07: Should we worry about rapid weight gain in infancy? L Marryat (UK)  
  OS7.08: Effects of family disposable income on development of height and BMI from birth up to eight years of age
R Bramsved (Sweden)  
18:00 - 19:30 AS5 - Symposium: Mobile and wireless technology (mHealth) to combat child and youth obesity: Exploring the scope for prevention and treatment.
  Chair: A Martin (UK)     
18:00 - 18:20 AS5.01: What is the current state of the art of mHealth technology and how is it used to engage children and adolescents to enable sustainable change in health behaviour for the prevention of obesity?
L A Condon (UK), M Caon (Switzerland), R Rashid (UK)  
18:20 - 18:40 AS5.01: How can mHealth technology be implemented in the context of obesity treatment and what are potential barriers? What actions should be undertaken from the medical research perspective to empower mHealth technologies as a tool for obesity treatment? L A Condon (UK), M Caon (Switzerland), R Rashid (UK)  
18:40 - 19:00 AS5.01: What are the ethical concerns and how could they be approached? L A Condon (UK ), M Caon (Switzerland), R Rashid (UK)   
19:00 - 19:30 Discussion  EASO Patient Council: O Andreasson (Sweden) and S Sigurdardottir (Iceland) and speakers  
18:00 - 19:30 Industry Supported Sessions
18:00 - 19:30 EASO Industry Supported Session: Satellite Symposium (Refer to page 60)   F4+F5 HALL
  Chair: H Toplak (Austria)    
  Requirements for successful weight management    
  BMI - no valid indicator for body composition D McCarthy (UK)  
  Use of Meal Replacement Strategies in Long-term Weight Management A Sharma (Canada)  
  Timing in training and nutrition M Halle (Germany)  
18:00 - 19:30 IFSO-EC Industry Supported Session /    
  Further information will be available in due course     
18:00 - 19:30 Poster Pitches 
18:00 - 19:30 Poster Networking and Poster Pitches    EXHIBITION AREA
  PP1 - Basic Science and Experimental Approaches   F1 HALL
  Chairs: E Blaak (The Netherlands),  S Dickson (Sweden)    
PP1.01 Alex3, a member of the Armcx family of proteins: a novel actor in the control of energy homeostasis
F Villarroya (Spain)  
PP1.02 Aldosterone is not associated with insulin-mediated microvascular recruitment and insulin sensitivity in abdominally obese, but otherwise healthy me M Schütten (The Netherlands)  
PP1.03 Obesity-associated alterations of glucose metabolism are ameliorated after chronic stimulation of abdominal vagus nerve
C H Malbert (France)  
PP1.04 Antioxidant treatment suppresses β3-adrenergic receptor agonist-induced browning of adipose tissue E Peris (Sweden)  
PP1.05 A candidate-based RNAi screen identifies regulators of adiponectin secretion in primary human adipocytes P Petrus (Sweden)  
PP1.06 Baseline subcutaneous adipocyte volume associates with improvements in pulse wave velocity following significant weight loss
J Bäckdahl (Sweden)  
PP1.07 Water soluble fraction of environmental particles induces mitochondrial dysfunction in macrophages followed by adipocyte dysfunction R Gat (Israel)  
PP1.08 65 years of longitudinal change in birth weight J Celind (Sweden)  
PP1.09 Brain reward activity is not associated with body weight and body composition – a PREVIEW study M Drummen (The Netherlands)  
PP1.10 Ghrelin changes food preference from high fat diet to chow in schedule-fed-rats T Bake (Sweden)  
PP1.11 Centrally administered ghrelin acutely influences food choice in rodents E Schéle (Sweden)  
PP1.12 A Difference in Fatty Acid Composition of Isocaloric High-Fat Diets Alters Metabolic Flexibility in Male C57BL/6JOlaHsd Mice
J Keijer (The Netherlands)  
PP1.13 Adipocytokines-autophagy crosstalk in adipose tissue and adipocytes - relevance to adipose tissue dysfunction in obesity N Goldstein (Israel)  
PP1.14 Plasma levels of retinol binding protein (RBP-4) in relation to metabolic syndrome components in elderly subject
J Chudek (Poland)  
PP1.15 Postprandial modifications of oxidative stress and mRNA expression in subjects with abdominal obesity
JF Martinez Valis (Spain)  
PP1.16 What is Normal? – Compartmental Fat and Muscle Quantification in a Large Scale Population Study using Magnetic Resonance Imaging
J WEST (Sweden)  
  PP2 - Health, Behaviour and Environment   F2 HALL
  Chairs: S Lehtinen-Jacks (Finland), T Visscher (The Netherlands)     
PP2.01 Childhood body size and the future risk of morphologically different variants of malignant melanoma
K Meyle (Denmark)  
PP2.02 High childhood body mass index and gain in body mass index during childhood increases the risk of early adult ischemic stroke
L Haugaard (Denmark)  
PP2.03 Abstract withdrawn    
PP2.04 Evidence for intrauterine factors explaining the association between birth weight and later body mass index using a natural experiment of twinning: A study on 27 twin cohorts participating in the CODATwins project
A Jelenkovic (Finland)  
PP2.05 Dietary patterns are associated with changes of visceral fat accumulation in adults: Tehran Lipid and Glucose Study
Z Bahadoran (Iran)  
PP2.06 Enhancing or diminishing autonomy for obesity prevention: An analysis of the ‘intrusiveness’ of policy recommendations to the Australian government
E Haynes (Australia)  
PP2.07 Intentional weight loss attempts among adults in England: Prevalence and trends over time, 1997-2013
C Piernas (UK)  
PP2.08 An analysis of behaviour change techniques used in a sample of gestational weight management trials
H Soltani (UK)  
PP2.09 Burden of Cancer attributable to high Body Mass Index (BMI) in the Republic of Ireland for 1990 and 2013
S Chakraborty (Ireland)  
PP2.10 Secular changes in well-being of young Swedes in relation to weight status: The ‘Grow up Gothenburg’ Studies
E Brann (Sweden)  
PP2.11 A large hip is protective against hip fracture S Klingberg (Sweden)  
  PP3 - Clinical Management   F3 HALL
  Chairs:  M Holecki (Poland), U Pagotto (Italy)    
PP3.01 Comparison of anthropometric parameters in the evaluation of risk of cardiometabolic comorbidities in patients with morbid obesity
J Neves (Portugal)  
PP3.02 Hepatic left lobe volume as an indicator of adiposity and related metabolic abnormalities in patients with NAFLD
N Vikram (India)  
PP3.03 Body Mass Index Standard Deviation Score (BMI SDS) in children with severe obesity: need for alternatives
P B Juliusson (Norway)
PP3.04 Obese men with type 2 diabetes (T2DM) and testosterone deficiency achieve progressive weight loss and improved glycaemic control during 8 years treatment with injectable testosterone undecanoate (TU) compared to untreated controls
F Saad (Germany)  
PP3.05 Increased basal lipolysis between two and five years after gastric bypass surgery associates with decreased insulin sensitivity
D Andersson (Sweden)
PP3.06 Modifications of Resting Energy Expenditure after surgical or medical weight loss: is there any difference?
E Bordigato (Italy)  
PP3.07 Long-term effects of bariatric surgery on gall bladder disease in the Swedish obese subjects study
A Anveden (Sweden)  
PP3.08 Conventional versus fast track anesthesia in an unselected group of patients undergoing revisional bariatric surgery S Pouwels (The Netherlands)  
PP3.09 Early weight loss responders to liraglutide 3.0 mg achieved greater weight loss and regression to normoglycaemia, and reduced development of T2D at 3 years, versus early non-responders in the SCALE Obesity and Prediabetes trial
S Madsbad (Denmark)
PP3.10 Cost-effectiveness of the behavioral antenatal care intervention programme Mighty Mums
H Gyllensten (Sweden)
PP3.11 Abstract withdrawn    
PP3.12 Effect of amino acids on gastric emptying and gut hormone secretion in nondiabetic obese and lean subjects
A Gerspach (Switzerland)  
PP3.13 Obese and overweight hypogonadal men lose weight with long-term treatment with injectable testosterone undecanoate (TU): real-life data from a controlled registry study
F Saad (UK)  
PP3.14 Liraglutide 3.0 mg in obese/overweight adults with or without prediabetes with baseline BMI <35 vs ≥35 kg/m² in the SCALE Obesity and Prediabetes 56-week randomised, double-blind, placebo-controlled trial
J Wilding (UK)  
PP3.15 Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass. A single centre experience
S Carandina (France)  

Friday, June 3, 2016
08:00 - 09:30 Joint Plenary Session 
  PL4 - Effects of obesity and bariatric surgery on pregancy   MAIN HALL
  Chairs: JM Chevallier (France), L Busetto (Italy)    
08:00 - 08:20 PL4.01: Effect of obesity on mother and child M Blomberg (Sweden)  
08:20 - 08:40 PL4.02: Does bariatric surgery improve pregnancy outcomes K Johansson (Sweden)  
08:40 - 09:00 PL4.03: Complications and compliancy problems during pregnancy J Nizard (France)  
09:00 - 09:20 PL4.04: Surgical Challenges during pregnancy in bariatric patients L Granström (Sweden)  
09:30 - 11:00  Review/Workshop Sessions 
09:30 - 11:00 RS16 - Ectopic fat   F3 HALL
  Chair: B Staels (France)     
09:30 - 10:00  RS16.01: Perivascular fat and its role in cardiovascular disease J Dyck (Canada)  
10:00 - 10:30 RS16.02: Novel aspects on the link between liver fat accumulation and hepatic or whole body insulin resistance
M Hofker (The Netherlands)  
10:30 - 10:45 RS16.03: The ELF score is associated with 1H-MRS measured liver fat content in Danish children with overweight and obesity
CE Fonvig (Denmark)  
10:45 - 11:00 RS16.04: Impaired skeletal muscle fatty acid handling in overweight and obese insulin resistant humans
B van der Kolk (The Netherlands)  
09:30 - 11:00  RS17 - Appetite and pleasures   G4 HALL
  Chairs: R Adan (The Netherlands), C Hardman (UK)     
09:30 - 10:00 RS17.01: MRI P Smeets (The Netherlands)  
10:00 - 10:30 RS17.02: Leptin suppresses the pleasure of eating R. Adan (The Netherlands) 
10:30 - 11:00 RS17.03: Neurology of hedonic eating H-R Berthoud (U.S.A)   
09:30 - 11:00 RS18 - How to address social inequalities in childhood obesity   F4+F5 HALL
  Chairs: P Nowicka (Sweden), L Lissner (Sweden)     
09:30 - 10:00 RS18.01: Paediatric assessment of social inequalities F Rasmussen (Sweden)  
10:00 - 10:30 RS18.02: Global patterns of inequality and childhood obesity S Ulijaszek (UK)  
10:30 - 11:00 RS18.03: Who are the interventions reaching? C Summerbell (UK)  
09:30 - 11:00 RS19 - How do you manage weight re-gain and comorbidities after surgery?   G3 HALL
  Chair: R Weiner (Germany)      
09:30 - 09:50 RS19.01: By lifestyle? N Finer (UK)  
09:50 - 10:10 RS19.02: By pharmacotherapy? U Pagotto (Italy)  
10:10 - 10:30 RS19.03: By surgery? M Suter (Switzerland)  
10:30 - 10:50 RS19.04: In adolescents? A Janson (Sweden)  
09:30 - 11:00 RS20 - EASO Patient Council Session: Ethical and Moral Challenges: Obesity as a Socially Defined Disease   F2 HALL
  Organised by EASO Patient Council     
  RS20.01: Making obesity a disease: why and why not B Hofmann (Norway)   
  RS20.02: Stigmatization of children and adults with obesity F Rasmussen (Sweden)   
  Discussion  EASO Patient Council Panel   
09:30 - 11:00 RS21 - IFSO-EC Session: How different national health care systems influence quality the management of the bariatric patient   F1 HALL
  Chair: R Peterli (Switzerland)    
09:30 - 09:45 RS21.01: Bariatric surgery care in Sweden I Näslund (Sweden)  
09:45 - 10:00 RS21.02: Bariatric surgery care in UK R Welbourn (UK)  
10:00 - 10:15 RS21.03: Bariatric surgery care in Germany S Weiner (Germany)  
10:15 - 10:30 RS21.04: Bariatric surgery care in Lithuania A Maleckas (Lithuania)  
10:30 - 11:00 Round table discussion    
09:30 - 11:00 RS22 - IFSO-EC Session - Innovation vs evidence   F6 HALL
  Chairs: J D´Argent (France), T Sövik (Norway)    
09:30 - 09:50 RS22.01: Introduction T Olbers (Sweden)  
09:50 - 10:05 RS22.02: Gastric plication M Fried (Czech Republic)  
10:05 - 10:20 RS22.03: SADI A Torres (Spain)  
10:20 - 10:35 RS22.04: Endobarrier JW Greve (The Netherlands)  
10:35 - 10:50 RS22.05: Other novel endoscopic procedures K Miller (Austria)  
10:50 - 11:00 Discussion    
11:00 - 11:30   Coffee Break/Exhibition  
11:30 - 13:00 Symposia and Oral Sessions 
11:30 - 13:00 AS6 - Bariatric Surgery in adolescents   F2 HALL
  Chairs: L Angrisani (Italy), T Olbers (Sweden)    
11:30 - 12:00 AS6.01: Pro T Inge (US)  
12:00 - 12:30 AS6.02: Con A Pietrobelli (Italy)  
12:30 - 12:45 AS6.03: Weight-related psychosocial problems in adolescents before and over 5 years after bariatric surgery – results from a Swedish nationwide study AMOS
K Järvholm (Sweden)  
12:45 - 13:00 AS6.04: The Adolescent Morbid Obesity Surgery (AMOS) study: five-year outcomes following laparoscopic Roux-en-Y gastric bypass in a Swedish nationwide study AJ Beamish (UK)  
11:30 - 13:00 AS7 - Symposium: Interactions of individual and contextual factors related to obesity-related behaviours and obesity in Europe
  Chair: J Lakerveld (The Netherlands)     
11:30 - 11:40  AS7.01: Introductory presentation on SPOTLIGHT background and overall aims. J Lakerveld (The Netherlands)   
11:40 - 12:00 AS7.01: Perceived barriers towards healthy eating in relation to dietary behaviours in adults across Europe
MGM de Pinho (The Netherlands)    
12:00 - 12:20  AS7.01: Neighbourhood patterns based on virtual audit (Google Street View) J-M Oppert (France)  
12:20 - 12:40  AS7.01: Environmental, social and individual correlates of obesity-related behaviours and BMI H Bardos (Hungary)   
12:40 - 13:00 AS7.01: Establishing lessons for policy, practice, and further research on multilevel obesity prevention approaches H Rutter (UK)    
11:30 - 13:00  AS8 - Symposium: Long term health consequences of childhood obesity   F4+F5 HALL
  Chair: J L Baker (Denmark)     
11:30 - 11:35 AS8.01: Welcome J L Baker (Denmark)   
11:35 - 12:05 AS8.01: Research from the Gothenburg School Health Record cohort J Kindblom (Sweden)  
12:05 - 12:35 AS8.01: Research from the Copenhagen School Health Records Register J L Baker (Denmark)   
12:35 - 12:45 AS8.01: Summation: importance of historical childhood records for contemporary populations T I A Sørensen (Denmark)  
12:45 - 13:00 Panel discussion  J L Baker (Denmark),
J Kindblom (Sweden),
T I A Sørensen (Denmark)
C Ohlsson (Denmark)
11:30 - 13:00  OS8 - Oral Session: Inter-organ crosstalk   F3 HALL
  Chair:  K Murphy (UK)     
  OS8.01: Brain network plasticity is associated with weight loss induced by chronic vagal stimulation
C Malbert (France)  
  OS8.02: Retinoblastoma protein knockdown favors oxidative metabolism and glucose and fatty acid disposal in muscle cells
J Ribot (Spain)  
  OS8.03: Short-chain fatty acids affect intracellular lipolysis in a human adipocyte model
E Canfora (The Netherlands)  
  OS8.04: Autonomic nervous imbalance induced by obesity is directly related to altered brain glucose metabolism
C Malbert (France)  
  OS8.05: Activation of gastrointestinal bitter taste receptors suppresses food intake and stimulates secretion of gastrointestinal peptide hormones in healthy men
J Ingram (New Zealand)  
  OS8.06: Does body composition influence food hedonics (food liking and wanting) in overweight and obese individuals?
M Hopkins (UK)  
  OS8.07: Selected Non-Communicable Disease (NCD) burden attributable to dietary risks and low physical activity for the Republic of Ireland in 1990 and 2013
S Chakraborty (Ireland)  
  OS8.08: Dynamism of the Hypothalamic Transcriptome Uncovers “Stages” during the Development of Diet-induced Obesity in Mice
T Tanaka (Japan)  
11:30 - 13:00  OS9 - IFSO-EC Oral Session: Mechanisms of metabolic surgery / Efect of surgery on commorbidities other than T2DM
  Chairs: J Pujol (Spain), G Prager (Austria)    
11:30 - 11:40 OS9.01: Subclinical hypothyroidism and its relation to obesity in patients before and after a roux-en-y gastric bypass
W Schijns (The Netherlands)  
11:40 - 11:50 OS9.02: Long-term effects of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome in patients with morbid obesity
K Shah (Denmark)  
11:50 - 12:00 OS9.03: Laparoscopic Roux-en-Y gastric bypass improves lipid profile and decreases cardiovascular risk. A 5-year longitudinal cohort study of 1049 patients D Gero (Switzerland)  
12:00 - 12:10 OS9.04: Continuous positive airway pressure dependency for patients with obstructive sleep apnea after laparoscopic Roux-en-Y gastric bypass: which patients?
C de Raaff (The Netherlands)  
12:10 - 12:20 OS9.05: Do pancreatobiliary secretions (pancreatic enzymes) influence glucose absorption after metabolic gut surgery? S Pierzynowski (Sweden)  
12:20 - 12:30 OS9.06: Leptin, inflammation, oxidative and carbonyl stress may play a pivotal role in insulin-resistance in non-severely obese patients (BMI <35kg/m2) with type 2 diabetes mellitus A Billeter (Germany)  
12:30 - 12:40 OS9.07: More uniform gastric pouch emptying in female patients with successful weight loss after gastric bypass surgery compared to poor weight loss L Deden (The Netherlands)  
12:40 - 12:50 OS9.08: Appetite and taste changes following sleeve gastrectomy and Roux-en-Y gastric bypass: influence of gender and type 2 diabetes and their relationship to weight-loss J Makaronidis (UK)  
12:50 - 13:00 Discussion    
11:30 - 13:00 AS9 - Symposium: Every BODY Matters: Addressing weight stigma in research, practice, and policy
  Chairs: S Kirk (Canada), C Fleetwood (Sweden)     
11:30 - 11:35  AS9.01: Welcome and introductions R Salas (Canada)   
11:35 - 11:55 AS9.01: A call to action to address weight stigma C Fleetwood (Sweden)   
11:55 - 12:15 AS9.01: Promising practices to address weight stigma A Alberga (Canada)   
12:15 - 12:35 AS9.01: Rewriting the script on weight stigma in health settings S Kirk (Canada)   
12:35 - 12:55 AS9.01: Making sure EveryBODY Matters J A Swift (UK)   
12:55 - 13:00  Questions and Discussion R Salas (Canada)   
11:30 - 13:00 OS10 - IFSO-EC Session: Multidisciplinary approach / Bariatric and metabolic surgery in extremes of age
  Chairs: L Lemmens (Belgium), A Torres (Spain)    
11:30 - 11:40 OS10.01: Mental health in adolescents 1 to 5 years after bariatric surgery – results from a Swedish nationwide study AMOS
K Järvholm (Sweden)  
11:40 - 11:50 OS10.02: Identifying of significant Obstructive Sleep Apnoea in the Obese Patient: Development of the DX-OSA Score and the aOSA-obese Score
D Godoroja (Romania)  
11:50 - 12:00 OS10.03: Intraperitoneal ropivacaine irrigation in patients undergoing bariatric surgery: A prospective randomized clinical trial
J Ruiz-Tovar (Spain)  
12:00 - 12:10 OS10.04: Helicobacter pylori eradication prior bariatric/metabolic surgery T Pintar (Slovenia)  
12:10 - 12:20 OS10.05: Assessment of social relationships among bariatric surgery patients and their association with pre-surgery body mass index and post-operative weight loss
U Tymoszuk (UK)  
12:20 - 12:30 OS10.06: Micronutrient status after laparoscopic sleeve gastrectomy S Gillon (Norway)  
12:30 - 12:40 OS10.07: Bariatric surgery improves quality of life and maintains nutritional status of older obese patients
Y Alassaf (France)  
12:40 - 12:50 OS10.08: Sleeve gastrectomy in teenagers: multi-institutional experience on syndromic and not syndromic patients
A Lossa (Italy)  
12:50 - 13:00 Discussion    
13:15 - 14:45 Lunc &  Exhibition 
13:15 - 14:45  Industry Supported Sessions 
13:15 - 14:45  EASO Industry Supported Session: Satellite Symposium   G3 HALL
  How can we achieve sustained weight loss?    
  Chair: B Ludvik (Austria)     
  Welcome and introduction 
B Ludvik (Austria)  
  Understanding the physiological barriers to sustained weight loss 
R Batterham (UK)  
  Therapeutic options for weight control   V Hainer (Czech Republic)  
  Matching the intervention to the individual    B Ludvik (Austria)  
  Putting words into action: changing practice to improve outcomes                          
All faculty  
13:15 - 14:45  Education Session
  Methods in appetite J Blundell (UK) F3 HALL
    S Higgs (UK)  
13:15 - 13:30 Basic assessment of appetite in the lab and preload designs. C Hardman (UK)  
13:30 - 13:45 Hedonics of Appetite: measuring liking and wanting G Finlayson (UK)  
13:45 - 14:00 Measuring satiety J Brunstrom (UK)  
14:00 - 14:15 Experimental design issues including dealing with demand characteristics and bias S Higgs (UK)  
14:15 - 14:45 Project Surgeries    
15:00 - 15:45   Plenary Session
15:00 - 15:45 PL5 - EASO Plenary Session: Re-thinking Appetite Regulation: the role of Energy Expenditure and its relationship to Energy Intake   F4+F5 HALL
  Chair: G Roman (Romania)     
  PL5.01: Re-thinking Appetite Regulation: the role of Energy Expenditure and its relationship to Energy Intake J Blundell (UK)   
15:00 - 15:45 PL6 - IFSO-EC Plenary Session: which operation for T2DM   MAIN HALL
  Chairs: D Cummings (US) , T Mala (Norway)    
15:00 - 15:15 PL6.01: Bypass P Schauer (US)  
15:15 - 15:30 PL6.02: Sleeve R Peterli (Switzerland)  
15:30 - 15:45 PL6.03: The Obesity Paradox H Buchwald (USA)  
15:45 - 16:15   Coffee Break/Exhibition  
16:15 - 17:45 Review/Workshop Sessions  
16:15 - 17:45  RS23 - Immuno metabolism   G3 HALL
  Chair: J-O Jansson (Sweden)    
16:15 - 16:45 RS23.01: The role of metabolites and their receptors in inflammation T Schwarz (Denmark)  
16:45 - 17:15 RS23.02: Inflammation as a therapeutic target in metabolic disease-an update M Donath (Switzerland)  
17:15 - 17:30 RS23.03: Preproglucagon (PPG) neurons in the hindbrain have IL-6 Receptor alpha (IL-6Ralpha) and show Ca2+ influx in response to IL-6 F Anesten (Sweden)  
17:30 - 17:45 RS23.04: The role of inflammation in the association between adiposity and subclinical atherosclerosis
T Christen (The Netherlands)  
16:15 - 17:45  RS24 - Cognitive sensory control of meal size   G4 HALL
  Chair: G Finlayson (UK)     
16:15 - 16:45 RS24.01: Decision making and food choice J Brunstrom (UK)  
16:45 - 17:15 RS24.02: The chemical senses and nutrition: the role of taste and smell in energy intake K de Graaf (The Netherlands)  
17:15 - 17:45 RS24.03: Memory and food choice S Higgs (UK)  
16:15 - 17:45  RS25 - Metabolically healthy obesity   F1 HALL
  Chairs: J Ambrosi-Gomez (Spain), C-E Flodmark (Sweden)     
  RS25.01: What is metabolically healthy obesity? M Blüher (Germany)  
  RS25.02: Does it exist? – adult perspective C Kramer (Canada)  
  RS25.03: Does it exist? – adolescent perspective JC Holm (Denmark)  
16:15 - 17:45  RS26 - IFSO-EC Video Session: How do I do it   F3 HALL
  Chairs: K Miller (Austria), L Granström (Sweden)    
16:15 - 16:30 RS26.01: Tactical issues in reoperation - overview R Weiner (Germany)  
16:30 - 16:40 RS26.02: Roux-en-Y Bypass P Schauer (U.S.A.)  
16:40 - 16:50 RS26.03: Omega loop/mini gastric bypass JM Chevallier (France)  
16:50 - 17:00 RS26.04: Sleeve gastrectomy D Nocca (France)  
17:00 - 17:10 RS26.05: SADI A Torres (Spain)  
17:10 - 17:20 RS26.06: Duodenal switch J Himpens (Belgium)  
17:20 - 17:45 Discussion    
16:15 - 17:45  Education Course: Motivation is the key of obesity treatment. This course will teach you to negotiate with your patients and motivate them to change   F2 HALL
  Chair: N Farpour-Lambert (Switzerland)     
  Motivation is the key of obesity treatment. This course will teach you to negotiate with your patients and motivate them to change D Durrer (Switzerland), A Golay (Switzerland)   
16:15 - 18:15  RS27 - State of the art management in the elderly   F4+F5 HALL
  Chair: C Tsigos (Greece)     
16:15 - 16:35 RS27.01: The obesity-depression link in older persons M Visser (The Netherlands)   
16:35 - 16:55` RS27.02: Weight loss in the elderly: emphasis on food or exercise? L Mathus-Vliegen (The Netherlands)  
16:55 - 17:15 RS27.03: Nutrition on the aging process J Mathers (UK)  
17:15 - 17:35 RS27.04: What does the future hold? B Heitmann (Denmark)  
17:35 - 17:45 Discussion     
18:00 - 19:30 Oral Session and Sympsoium
18:00 - 19:30 AS10 - Symposium: Prevention of type-2 diabetes in overweight and obese – first results from the large PREVIEW Project   G4 HALL
  Chair: A Raben (Denmark)     
18:00 - 18:15 AS10.01: Prevention of type-2 diabetes (T2D): Why is the PREVIEW project important? Comparison with previous T2D prevention studies A Raben (Denmark)  
18:15 - 18:30 AS10.02: The PREVIEW intervention study: how does 8-weeks weight loss and 4 mths weight maintenance phase influence T2D risk factors? M Fogelholm (Finland)  
18:30 - 18:45 AS10.03: Prevention of type-2 diabetes and brain food-reward activity M S Westerterp-Plantenga , M Drummen,  T Adam (The Netherlands)  
18:45 - 19:00 AS10.04: Prevention of type-2 diabetes in overweight and obese adolescents: Associations with gender, puberty stage and body composition MS Westerterp-Plantenga, E Dorenbos, A Vreugdenhil (The Netherlands)  
19:00 - 19:15 AS10.05: Prevention of type-2 diabetes and the role of protein: Evidence from population-based studies in PREVIEW D Sluik, E Feskens (The Netherlands)  
19:15 - 19:30 AS10.06: Prevention of type-2 diabetes: Importance of psycho-social variables beyond diet and physical activity W Schlicht, S Hansen, J Thurn (Germany)  
18:00 - 19:30 Industry Supported Sessions
18:00 - 19:30 EASO Industry Supported Session: Satellite Symposium global nutrition philosophy and recommendations for health and wellness in the 21st century   G3 HALL
  Opening remarks John Agwunobi, (U.S.A.)  
  A global nutrition philosophy to support healthy aging David Heber, (U.S.A.)  
  Understanding appetite, food preference and behavior and informing recommendations Carel le Roux, (Ireland)  
  From recommendations to practice: Example of a novel community intervention approach Sai Krupa Das, (U.S.A.)  
  Panel discussion    
18:00 - 19:30 IFSO-EC Industry Supported Session     
  Further information will be available in due course     
18:00 - 19:30 Poster Pitches 
18:00 - 19:30 Poster Networking and Poster Pitches    F2 HALL
  PP4 - Health, Behaviour and Environment    
  Chairs: M Bes-Rastrollo (Spain), J Lakerveld (The Netherlands)    
PP4.01 Physical activity is inversely associated with body fat but not with BMI in preschool children (SPLASHY) A Arhab (Switzerland)  
PP4.02 Detailed analyses of the relation between childhood BMI and gain in height during puberty, separated into different components
A Holmgren (Sweden)  
PP4.03 Maternal Blood Lipid Profile during Pregnancy impacts on Child Adiposity: Findings from the ROLO Study
A Geraghty (Ireland)  
PP4.04 Healthy diet score: design, application and association with future overweight G Eiben (Sweden)  
PP4.05 Reframing corporations and regulatory activity in the obesity epidemic G Williams (UK)  
PP4.06 Obesity continues to increase in the majority of the population in mid-Sweden – A 12-year follow-up
A Molarius (Sweden)  
PP4.07 Treating obesity by reducing the speed of eating P Södersten (Sweden)  
PP4.08 Abstract withdrawn    
PP4.09 Mobile applications (‘apps’) for weight management: current market characteristics C Nikolaou (Belgium)  
PP4.10 A critical discourse analysis of Canadian obesity prevention public health policies X Salas (Canada)  
PP4.11 Improving cardiometabolic health by adjusting the obesogenic environment in severe mentally ill inpatients: a randomised controlled trial A Looijmans (The Netherlands)  
  PP5 - Clinical Management II F3 HALL  
  Chairs: G Roman (Romania), J Stubbs (UK)    
PP5.01 Mental health status in treatment-seeking young adults with obesity compared with matched normal-weight young adults: case-control study
H Dreber (Sweden)  
PP5.02 Who’s getting engaged? Factors associated with parent engagement when upscaling the PEACH™ program for overweight primary school aged children
L Daniels (Australia)  
PP5.03 Body Composition after Gastric Bypass and Duodenal Switch – a Comparison with BMI-matched Non-operated Controls
M Skogar (Sweden)  
PP5.04 Reflux Management With the LINX® System for Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy
M Elshafei (Germany)
PP5.05 The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnoea
A Gabrielsen (Norway)
PP5.06 Revisional surgery for insufficient weight loss after Roux-en-Y gastric bypass: Addition of different restrictive and malabsorptive modifications
M Kraljevic (Switzerland)
PP5.07 Type 2 Diabetes, Obesity and Laparoscopic Sleeve Gastrectomy: long-term follow up, review of the criteria for diabetes remission and relationship with weight “regain”
D Capoccia (Italy)
PP5.08 Gastric bypass specifically alters liver metabolism as compared to sleeve gastrectomy in subjects matched for postoperative weight
S Ledoux (France)  
P5.09 Serum lipidomics reveals greater early suppression of circulating very-long chain ceramides in gastric bypass compared to gastric banding
B Kayser (France)  
PP5.10 Predictors of secondary hyperparathyroidism after bariatric surgery in patients with vitamin D deficiency F Cunha (Portugal)
PP5.11 Increased bone resorption following gastric bypass surgery is related to the procedure itself, weight loss and changes in secreted Wnt antagonists
D Hofsø (Norway)
PP5.12 Cardiac fitness improvement after RYGB S Polovina (Serbia)  
PP5.13 Food craving and weight loss: An integrated analysis of the effects of prolongedrelease naltrexone/bupropion on the cravings and mood sub-scales of the Control of Eating Questionnaire
K Glider (United States)  
PP5.14 Efficacy of naltrexone/bupropion, administered as recommended in clinical practice, compared with usual care for weight management
A Halseth (United States)  
PP5.15 Gender differences in the prevalence of malnutrition in patients with morbid obesity E Krzizek (Austria)  

Saturday, June 4, 2016
08:30 - 09:15 Plenary Lecture 
08:30 - 09:15 PL7 - EASO Plenary Session: Pros and cons of the diagnosis of Food Addiction for tackling the obesity epidemic   F4+F5 HALL
  Chair: S Dickson (Sweden)     
  PL7.01: Pros and cons of the diagnosis of Food Addiction for tackling the obesity epidemic J Hebebrand (Germany)  
08:30 - 09:15 PL8 - IFSO-EC Plenary Session: Plastic Surgery after massive weight loss   G3 HALL
  Chairs: A Elander (Sweden), M Fried (Czech Republic)    
08:30 - 09:05 PL8.01: Plastic Surgery after massive weight loss A Elander (Sweden)  
09:05 - 09:15 PL8.02: Desire for body contouring surgery risk factor for weight regain? VM Montpellier (The Netherlands)  
09:15 - 09:45  EOS 2016 Closing Ceremony 
  Poster Award Presentations, 2017 Congress presentations       F4+F5 HALL
09:45 - 11:15 Oral Sessions  
09:45 - 11:15 RS28 - Joint Session: Mental health and behaviour after bariatric surgery   F2 HALL
  Chairs: F Pattou (France), F Rasmussen (Sweden)     
09:45 - 10:10 RS28.01: The Psychosocial Burden of Obesity D Sarwer (U.S.A)  
10:10 - 10:35 RS28.02: Hedonic reward B Schultes (Switzerland)  
10:35 - 11:00 RS28.03: Food palatability M Bueter (Switzerland)  
11:00 - 11:15 Discussion    
09:45 - 11:15 OS11 - Oral Session: Clinical management II   G3 HALL
  Chairs: J Jordan (Germany), Dragan Micic (Serbia)    
  OS11.01: Abstract withdrawn    
  OS11.02: Biopsy-proven liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients
M Luger (Austria)  
  OS11.03: Metabolic outcomes after an 8 weeks low-calorie-diet in overweight, prediabetic individuals: the role of gender in the PREVIEW study
P Christensen (Denmark)  
  OS11.04: Differential expression of tumorogenesis-related genes in blood leukocytes of obese women with and without breast cancer
A Crujeiras (Spain)  
  OS11.05: Insulin/IGF-1 signalling in colon mucosa following diet-induced weight loss and its implications for colorectal tumorigenesis: the INTERCEPT study
G Campanella (UK)  
  OS11.06: Fibrinolysis Shutdown in Morbid Obesity: Tissue Plasminogen Activator Resistance and the Effects of Bariatric Surgery A Morton (U.S.A)  
  OS11.07: Weight loss improves impaired muscle capillary recruitment in abdominally obese men: effects on metabolic insulin resistance
Y H. Kusters (The Netherlands)  
  OS11.08: Host-microbiota-environment interactions in calorie restriction: an integrative view of multi-dimensional data
M Dao (France)  
09:45 - 11:15 OS12: Oral Session: Obesity and (cardio)metabolic risk   G4 HALL
  I Bosaeus (Sweden), I Larsson (Sweden)    
  OS12.01: The relative contributions of visceral fat and liver fat to insulin resistance and insulin secretion in men and women: the NEO study
R Mutsert (The Netherlands)  
  OS12.02: Phospholipid transfer protein (PLTP) and metabolic diseases L Lebrun (France)  
  OS12.03: Mechanisms regulating insulin response to intragastric glucose in nondiabetic obese and lean subjects
A Gerspach (Switzerland)  
  OS12.04: Title: Ectopic fat and the phenotype of sarcopenic obesity in metabolically healthy and metabolically abnormal middle-aged women
E Poggiogalle (Italy)  
  OS12.05: Chronic intermittent hypoxia impairs insulin sensitivity but improves whole-body glucose tolerance by activating skeletal muscle AMP-activated protein kinase in mice
B Guigas (The  Netherlands)  
  OS12.06: Restoring the circadian clock with melatonin can reduce thrombotic risk associated with obesity
R King (UK)  
  OS12.07: Abstact withdrawn    
  OS12.08: Serum ceramides are linked to low microbiome richness and diabetes risk in overweight and obese subjects
B Kayser (France)  
09:45 - 11:15 Hot Topic Oral Session (EASO)    F1 HALL
  Chair: S Dickson (Sweden)    
  Looking for cues – infant hunger and satiety during milk feeding Netalie Shloim (UK)  
  Success and failure of the National Childhood Measurement Programme in England Sonia Saxena (UK)  
  Three genetic loci involved in both variation of body mass index and anorexia nervosa risk Anke Hinney (Germany)  
  Inhibitory control training for appetitive behaviour change: A metaanalytic investigation of mechanisms of action and moderators of effectiveness Andrew Jones (UK)  
  Protein malabsorption and increase in food intake after Mini Gastric Bypass but not after Roux-en-Y Gastric Bypass Maude Le Gall (France)  
  Liraglutide 3.0 mg reduced the risk of developing type 2 diabetes and decreased body weight in the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled trial Luc Van Gaal (Belgium)  
09:45 - 11:15 OS13 - IFSO-EC Session: Abstract Prize - voting session   F3 HALL
  Chairs: R Peterli (Switzerland), R Batterham (UK)    
09:45 - 09:55 OS13.05: Resting energy expenditure after Roux-en Y gastric bypass surgery B Schultes (Switzerland)  
09:55 - 10:05 OS13.01: Long-Term Effects of Roux-en–Y Gastric Bypass on Type 2 Diabetes Mellitus in Patients with Morbid Obesity BJ Nergård (Norway)  
10:05 - 10:15 OS13.02: Bleeding during laparoscopic gastric bypass as a risk factor for postoperative complications. A cohort study from the Scandinavian Obesity Surgery Registry E Stenberg (Sweden)  
10:15 - 10:25 OS13.03: Reduction of Short-term Morbidity in the Standardized Fully Stapled Laparoscopic Roux-en–Y Gastric Bypass: A Single Centre Study on 10 000 Patients G Uijtterhaegen (Belgium)  
10:25 - 10:35 OS13.04: Early effects on glycemic control in Sleeve Gastrectomy and Roux-en-Y Gastric Bypass patients with type-2 diabetes V Wallenius (Sweden)  
10:35 - 10:45 OS13.06: Antrum preservation seems to accelerate gastric emptying after laparoscopic sleeve gastrectomy without having effects on weight loss. M Garay Solà (Spain)  
10:45 - 10:55 OS13.07: Five-year results after Vertical Sleeve Gastrectomy (VSG) for severe obesity TN Flølo (Norway)  
10:55 - 11:05 OS13.08: Secondary hyperparathyroidism 2 years after proximal and distal gastric bypass – a randomised controlled study M Svanevik (Norway)  
11:15 - 11:45   Coffee Break/Commercial Exhibition 
11:45 - 13:15  Association/Review/Workshop Sessions 
  Merged Programme: EASO and IFSO-EC Sessions    
11:45 - 13:15  RS29 - Review Session: Adipogenesis   G3 HALL
  Chair: S Enerbäck (Sweden)     
11:45 - 12:15 RS29.01: Adipogenesis and its role in metabolic disorders A Bouloumie (France)  
12:15 - 12:45 RS29.02: How does the origin of adipocytes impact on metabolic health? C Dani (France)  
12:45 - 13:00 RS29.03: ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion
D Bauters (Belgium)  
13:00 - 13:15 RS29.04: Effects of omega-3 PUFAs on brown and beige adipocyte differentiation and activation
T Lopez (Spain)  
11:45 - 13:15  RS30 - Symposium: Physical activity and nutritional assessment in children.   G4 HALL
  Chair: C-E Flodmark (Sweden), I Lissau (Sweden)    
11:45 - 12:15 RS30.01: What is new and reliable? M Lof (Sweden)  
12:15 - 12:30 RS30.02: Adolescents' communication of high calorie low nutrient food items in image-based social media C Holmberg (Sweden)  
12:30 - 12:45 RS30.03: School effects on sedentary behaviour in 5-6 year old children J Clarke (UK)  
12:45 - 13:00 RS30.04: Perceived fussy eating in children at 14 months of age and subsequent use of maternal feeding practices at 2 years – the NOURISH cohort R Byrne (Australia)  
13:00 - 13:15 RS30.05: Overweight children consume larger meals: data from the Diet and Nutrition Survey of Infants and Young Children (DNSIYC) H Syrad (UK)  
11:45 - 13:15  RS31 - IFSO-EC Review Session: Long term side effects of bariatric surgery   F4+F5 HALL
  Chairs: N Zundel (USA), B Eliasson (Sweden)    
11:45 - 12:07 RS31.01: Meal related symptoms after gastric bypass - dumping syndrome and reactive hypoglycaemia
A Laurenius (Sweden)  
12:07 - 12:29 RS31.02: How to handle internal hernias UKsetting H Gislasson (Norway)  
12:29 - 12:51 RS31.03: Abdominal pain after bariatric surgery A Maleckas (Lithuania)  
12:51 - 13:13 RS31.04: Too much weight loss R Batterham (UK)  
11:45 - 13:15  RS32 - Review Debate: Can we learn anything from Omics?   F2 HALL
  Chair: M Ryden (Sweden)     
11:45 - 12:15 RS32.01: Yes B van Ommen (The Netherlands)   
12:15 - 12:45  RS32.02: No D Langin (France)  
12:45 - 13:00  Discussion     
13:15 - 14:45 Joint Closing Plenary Session 
13:15 - 14:45 PL9 - Long term effects of bariatric surgery   F4+F5 HALL
  Chairs: M Suter (Switzerland), I Näslund (Sweden)    
13:15 - 13:35 PL9.01: Improvements in NAFLD F Pattou (France)   
13:35 - 13:55 PL9.02: Effects on Depression Changes in Quality of Life, Body Image and Sexual Functioning
D Sarwer (U.S.A.)  
13:55 - 14:15 PL9.03: Bariatric surgery and hypertension J Jordan (Germany)  
14:15 - 14:35 PL9.04: Kidney Diseases in Obesity and Bariatric Surgery G Mingrone (Italy)